The neuroendoscopy market size has grown strongly in recent years. It will grow from $0.78 billion in 2025 to $0.83 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, expansion of neurosurgical treatment options, adoption of endoscopic surgical techniques, availability of advanced visualization tools, growth in specialized neurosurgery centers.
The neuroendoscopy market size is expected to see strong growth in the next few years. It will grow to $1.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive brain surgeries, rising investments in advanced surgical imaging, expansion of pediatric neurosurgery services, growing focus on faster patient recovery, continuous innovation in neuroendoscopic instruments. Major trends in the forecast period include increasing adoption of minimally invasive neuroendoscopic procedures, rising use of hd and 4k visualization systems, growing demand for flexible neuroendoscopes, expansion of pediatric neuroendoscopy applications, enhanced focus on surgical precision and safety.
The increasing incidence of brain tumors is expected to drive the growth of the neuroendoscopy market in the coming years. Brain tumors are abnormal cell growths within the brain or spinal canal, which can either be malignant or benign. These tumors can impact brain function and often require surgical, radiological, or medical treatments, depending on their type and location. The rise in brain tumor cases is linked to better diagnostic imaging and increased exposure to environmental risk factors, including ionizing radiation and industrial pollutants. Neuroendoscopy provides a minimally invasive method for treating brain tumors, enabling tumor removal or biopsy with reduced trauma, quicker recovery, and fewer complications. For example, in 2023, Cancer Australia reported approximately 1,924 new cases of brain cancer, making up 1.2% of all new cancer cases in the country. Thus, the growing number of brain tumor cases is contributing to the growth of the neuroendoscopy market.
Companies in the neuroendoscopy market are focusing on innovations such as the biportal endoscopic surgical system to improve surgical precision, reduce invasiveness, speed up recovery, and extend the scope of treatable neurological conditions. A biportal endoscopic system uses two entry points one for viewing and one for operating. This approach offers clearer imaging, more accurate procedures, and faster recovery times. For instance, in October 2023, Joimax, a US-based company, launched the iLESSYS biportal endoscopic system for spinal surgery, which enhances precision and freedom of movement through biportal access. The system features tools for triangulation, irrigation control, and tissue resection, supporting both biportal and bimanual techniques.
In August 2024, KARL STORZ, a German medical technology company, acquired Asensus Surgical Inc. for an undisclosed sum. This acquisition enhances KARL STORZ's capabilities in robotic surgery, enabling the provision of AI-driven, minimally invasive solutions that improve surgical precision and patient outcomes. Asensus Surgical Inc., based in the US, specializes in digital surgical technologies.
Major companies operating in the neuroendoscopy market are Medtronic plc, Stryker Corporation, Karl Storz SE & Co. KG, Carl Zeiss Meditec AG, Aesculap AG, B. Braun Melsungen AG, Richard Wolf GmbH, Integra LifeSciences Holdings Corporation, Schindler Endoskopie Technologie GmbH, Machida Endoscope Co. Ltd., Adeor Medical AG, Inova Technology GmbH, Zhejiang Tiansong Medical Instrument Co. Ltd., Tonglu WANHE Medical Instrument Co. Ltd., Olympus Corporation, Fujifilm Holdings Corporation, ConMed Corporation, Schoelly Fiberoptic GmbH, Endoservice GmbH, Ackermann Instrumente GmbH, XION Medical GmbH, Happersberger Otopront GmbH.
North America was the largest region in the neuroendoscopy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroendoscopy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neuroendoscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neuroendoscopy market by increasing costs of imported optical components, cameras, imaging sensors, precision instruments, and endoscopic manufacturing equipment. Hospitals and specialty neurosurgical centers in North America and Europe are most affected due to dependence on imported high-end devices, while Asia-Pacific faces higher costs in exporting advanced systems. These tariffs are increasing capital equipment expenditure and delaying technology upgrades. However, they are also encouraging localized assembly, regional supplier partnerships, and domestic production of neuroendoscopic systems.
The neuroendoscopy market research report is one of a series of new reports that provides neuroendoscopy market statistics, including neuroendoscopy industry global market size, regional shares, competitors with a neuroendoscopy market share, detailed neuroendoscopy market segments, market trends and opportunities, and any further data you may need to thrive in the neuroendoscopy industry. This neuroendoscopy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neuroendoscopy is a minimally invasive surgical method used to diagnose and treat neurological conditions, including brain tumors, epilepsy, and cerebrovascular disorders. It involves using specialized endoscopic instruments inserted through small incisions, providing a less invasive option compared to traditional surgery. The main objective is to deliver precise treatment with minimal damage to surrounding tissues, which leads to faster recovery, reduced infection risks, and lower healthcare expenses. This technique enhances surgical accuracy, improves patient outcomes, and aligns with the growing trend toward minimally invasive approaches in neurosurgery.
The primary products in neuroendoscopy include rigid neuroendoscopes, rigid fiberscopes, rigid videoscopes, and flexible neuroendoscopes. Rigid neuroendoscopes are straight, inflexible instruments frequently used in brain surgeries. They provide high-resolution imaging via a lens system, allowing surgeons to clearly view internal brain structures. These instruments are used in procedures such as tumor removal and endoscopic third ventriculostomy (ETV) for both adult and pediatric patients. The procedures are typically carried out by various end users, such as hospitals, clinics, and clinical laboratories.
The neuroendoscopy market consists of revenues earned by entities providing services such as minimally invasive neurosurgeries, diagnostic imaging, patient care, and post-operative recovery solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuroendoscopy market also includes sales of advanced endoscopic equipment, surgical tools, diagnostic imaging systems, and specialized surgical instruments used in neurosurgery. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The neuroendoscopy market size is expected to see strong growth in the next few years. It will grow to $1.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive brain surgeries, rising investments in advanced surgical imaging, expansion of pediatric neurosurgery services, growing focus on faster patient recovery, continuous innovation in neuroendoscopic instruments. Major trends in the forecast period include increasing adoption of minimally invasive neuroendoscopic procedures, rising use of hd and 4k visualization systems, growing demand for flexible neuroendoscopes, expansion of pediatric neuroendoscopy applications, enhanced focus on surgical precision and safety.
The increasing incidence of brain tumors is expected to drive the growth of the neuroendoscopy market in the coming years. Brain tumors are abnormal cell growths within the brain or spinal canal, which can either be malignant or benign. These tumors can impact brain function and often require surgical, radiological, or medical treatments, depending on their type and location. The rise in brain tumor cases is linked to better diagnostic imaging and increased exposure to environmental risk factors, including ionizing radiation and industrial pollutants. Neuroendoscopy provides a minimally invasive method for treating brain tumors, enabling tumor removal or biopsy with reduced trauma, quicker recovery, and fewer complications. For example, in 2023, Cancer Australia reported approximately 1,924 new cases of brain cancer, making up 1.2% of all new cancer cases in the country. Thus, the growing number of brain tumor cases is contributing to the growth of the neuroendoscopy market.
Companies in the neuroendoscopy market are focusing on innovations such as the biportal endoscopic surgical system to improve surgical precision, reduce invasiveness, speed up recovery, and extend the scope of treatable neurological conditions. A biportal endoscopic system uses two entry points one for viewing and one for operating. This approach offers clearer imaging, more accurate procedures, and faster recovery times. For instance, in October 2023, Joimax, a US-based company, launched the iLESSYS biportal endoscopic system for spinal surgery, which enhances precision and freedom of movement through biportal access. The system features tools for triangulation, irrigation control, and tissue resection, supporting both biportal and bimanual techniques.
In August 2024, KARL STORZ, a German medical technology company, acquired Asensus Surgical Inc. for an undisclosed sum. This acquisition enhances KARL STORZ's capabilities in robotic surgery, enabling the provision of AI-driven, minimally invasive solutions that improve surgical precision and patient outcomes. Asensus Surgical Inc., based in the US, specializes in digital surgical technologies.
Major companies operating in the neuroendoscopy market are Medtronic plc, Stryker Corporation, Karl Storz SE & Co. KG, Carl Zeiss Meditec AG, Aesculap AG, B. Braun Melsungen AG, Richard Wolf GmbH, Integra LifeSciences Holdings Corporation, Schindler Endoskopie Technologie GmbH, Machida Endoscope Co. Ltd., Adeor Medical AG, Inova Technology GmbH, Zhejiang Tiansong Medical Instrument Co. Ltd., Tonglu WANHE Medical Instrument Co. Ltd., Olympus Corporation, Fujifilm Holdings Corporation, ConMed Corporation, Schoelly Fiberoptic GmbH, Endoservice GmbH, Ackermann Instrumente GmbH, XION Medical GmbH, Happersberger Otopront GmbH.
North America was the largest region in the neuroendoscopy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroendoscopy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neuroendoscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neuroendoscopy market by increasing costs of imported optical components, cameras, imaging sensors, precision instruments, and endoscopic manufacturing equipment. Hospitals and specialty neurosurgical centers in North America and Europe are most affected due to dependence on imported high-end devices, while Asia-Pacific faces higher costs in exporting advanced systems. These tariffs are increasing capital equipment expenditure and delaying technology upgrades. However, they are also encouraging localized assembly, regional supplier partnerships, and domestic production of neuroendoscopic systems.
The neuroendoscopy market research report is one of a series of new reports that provides neuroendoscopy market statistics, including neuroendoscopy industry global market size, regional shares, competitors with a neuroendoscopy market share, detailed neuroendoscopy market segments, market trends and opportunities, and any further data you may need to thrive in the neuroendoscopy industry. This neuroendoscopy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neuroendoscopy is a minimally invasive surgical method used to diagnose and treat neurological conditions, including brain tumors, epilepsy, and cerebrovascular disorders. It involves using specialized endoscopic instruments inserted through small incisions, providing a less invasive option compared to traditional surgery. The main objective is to deliver precise treatment with minimal damage to surrounding tissues, which leads to faster recovery, reduced infection risks, and lower healthcare expenses. This technique enhances surgical accuracy, improves patient outcomes, and aligns with the growing trend toward minimally invasive approaches in neurosurgery.
The primary products in neuroendoscopy include rigid neuroendoscopes, rigid fiberscopes, rigid videoscopes, and flexible neuroendoscopes. Rigid neuroendoscopes are straight, inflexible instruments frequently used in brain surgeries. They provide high-resolution imaging via a lens system, allowing surgeons to clearly view internal brain structures. These instruments are used in procedures such as tumor removal and endoscopic third ventriculostomy (ETV) for both adult and pediatric patients. The procedures are typically carried out by various end users, such as hospitals, clinics, and clinical laboratories.
The neuroendoscopy market consists of revenues earned by entities providing services such as minimally invasive neurosurgeries, diagnostic imaging, patient care, and post-operative recovery solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuroendoscopy market also includes sales of advanced endoscopic equipment, surgical tools, diagnostic imaging systems, and specialized surgical instruments used in neurosurgery. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Neuroendoscopy Market Characteristics
3. Neuroendoscopy Market Supply Chain Analysis
4. Global Neuroendoscopy Market Trends and Strategies
5. Neuroendoscopy Market Analysis of End Use Industries
7. Global Neuroendoscopy Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Neuroendoscopy Total Addressable Market (TAM) Analysis for the Market
9. Neuroendoscopy Market Segmentation
10. Neuroendoscopy Market Regional and Country Analysis
11. Asia-Pacific Neuroendoscopy Market
12. China Neuroendoscopy Market
13. India Neuroendoscopy Market
14. Japan Neuroendoscopy Market
15. Australia Neuroendoscopy Market
16. Indonesia Neuroendoscopy Market
17. South Korea Neuroendoscopy Market
18. Taiwan Neuroendoscopy Market
19. South East Asia Neuroendoscopy Market
20. Western Europe Neuroendoscopy Market
21. UK Neuroendoscopy Market
22. Germany Neuroendoscopy Market
23. France Neuroendoscopy Market
24. Italy Neuroendoscopy Market
25. Spain Neuroendoscopy Market
26. Eastern Europe Neuroendoscopy Market
27. Russia Neuroendoscopy Market
28. North America Neuroendoscopy Market
29. USA Neuroendoscopy Market
30. Canada Neuroendoscopy Market
31. South America Neuroendoscopy Market
32. Brazil Neuroendoscopy Market
33. Middle East Neuroendoscopy Market
34. Africa Neuroendoscopy Market
36. Neuroendoscopy Market Competitive Landscape and Company Profiles
37. Neuroendoscopy Market Other Major and Innovative Companies
40. Neuroendoscopy Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Neuroendoscopy Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses neuroendoscopy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for neuroendoscopy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuroendoscopy market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Rigid Neuroendoscope; Rigid Fiberscopes; Rigid Videoscopes; Flexible Neuroendoscopes2) By Patient: Adult; Pediatric
3) By Application: Tumor Removal; Endoscopic Third Ventriculostomy
4) By End User: Hospitals And Clinics; Neurosurgical Centers; Other End-Users
Subsegments:
1) By Rigid Neuroendoscope: Ventriculoscope; Ventricular Neuroendoscope; Skull Base Neuroendoscope2) By Rigid Fiberscopes: Non Video Transmitting Fiberscopes; High Definition Fiberscopes; Disposable Rigid Fiberscopes
3) By Rigid Videoscopes: Camera Integrated Videoscopes; HD Or 4K Videoscopes; Modular Videoscopes
4) By Flexible Neuroendoscopes: Fiber Optic Flexible Endoscopes; Video Flexible Endoscopes; Steerable Flexible Endoscopes
Companies Mentioned: Medtronic plc; Stryker Corporation; Karl Storz SE & Co. KG; Carl Zeiss Meditec AG; Aesculap AG; B. Braun Melsungen AG; Richard Wolf GmbH; Integra LifeSciences Holdings Corporation; Schindler Endoskopie Technologie GmbH; Machida Endoscope Co. Ltd.; Adeor Medical AG; Inova Technology GmbH; Zhejiang Tiansong Medical Instrument Co. Ltd.; Tonglu WANHE Medical Instrument Co. Ltd.; Olympus Corporation; Fujifilm Holdings Corporation; ConMed Corporation; Schoelly Fiberoptic GmbH; Endoservice GmbH; Ackermann Instrumente GmbH; XION Medical GmbH; Happersberger Otopront GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Neuroendoscopy market report include:- Medtronic plc
- Stryker Corporation
- Karl Storz SE & Co. KG
- Carl Zeiss Meditec AG
- Aesculap AG
- B. Braun Melsungen AG
- Richard Wolf GmbH
- Integra LifeSciences Holdings Corporation
- Schindler Endoskopie Technologie GmbH
- Machida Endoscope Co. Ltd.
- Adeor Medical AG
- Inova Technology GmbH
- Zhejiang Tiansong Medical Instrument Co. Ltd.
- Tonglu WANHE Medical Instrument Co. Ltd.
- Olympus Corporation
- Fujifilm Holdings Corporation
- ConMed Corporation
- Schoelly Fiberoptic GmbH
- Endoservice GmbH
- Ackermann Instrumente GmbH
- XION Medical GmbH
- Happersberger Otopront GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.83 Billion |
| Forecasted Market Value ( USD | $ 1.09 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
